Bosnalijek launched 81 new products in the last five years

SARAJEVO, (Patria) - The largest domestic pharmaceutical manufacturer, Bosnalijek, recently launched a new product, Melnot®. With this melatonin-based food supplement, Bosnalijek has launched a total of 81 new products in the last five years.

In this way, Bosnalijek has once again confirmed its leading position, not only in the pharmaceutical but also in the overall manufacturing industry of Bosnia and Herzegovina.

“Bosnalijek’s product portfolio includes prescription drugs, over-the-counter drugs, food supplements, medical devices, special-purpose cosmetics, and disinfectants – a total of 244 registered products based on 132 molecules. Almost 90 percent of the product portfolio consists of drugs, which are the most demanding and strictly regulated pharmaceutical products. In addition, 184 products, or three-quarters of the total number of products, are the result of Bosnalijek’s own development, while 60 products are the result of cooperation with renowned licensing partners. Bosnalijek is one of the few companies in the region that has maintained its own development, to which it continuously invests and constantly adapts its product portfolio to market needs.

The strategic orientation towards meeting the needs of our clients and product users represents a strong support in the market competition with competitors from the most developed countries in the world,” the company stated.

The company’s positive development trend has been maintained even in the most difficult conditions of various market limitations during the COVID-19 pandemic, and since the beginning of the pandemic until today, as many as 27 new products have been launched on the market.

All of this has ensured stable business growth in the domestic market, as well as worldwide, as Bosnalijek's products are sold on three continents and in 22 countries.